Beijing Konruns Pharmaceutical Co., Ltd. Class ASSE: 603590

Announcement on Lifting Sales Restrictions and Listing for Circulation in the 2nd Restriction Period for the 1st Grant under 2023 Restricted Stock Incentive Plan

· Issued by Beijing Konruns Pharmaceutical Co., Ltd. Class A via Shanghai Stock Exchange
The total number of shares to be listed and circulated this time is 796,000 shares; the listing and circulation date is September 22, 2025.

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment